- Coordinates
- PDB Format
- Method
- X-RAY DIFFRACTION 3.17 Å
- Oligo State
- hetero-1-1-1-1-mer
- Ligands
- 5 x PO4: PHOSPHATE ION(Non-functional Binders)
- 1 x GOL: GLYCEROL(Non-functional Binders)
- 1 x VLH: (2S,4R)-1-[(2R)-2-[3-[2-[4-[3-[4-[(1R,5S)-3-[3-azanyl-6-(2-hydroxyphenyl)pyridazin-4-yl]-3,8-diazabicyclo[3.2.1]octan-8-yl]pyridin-2-yl]oxycyclobutyl]oxypiperidin-1-yl]ethoxy]-1,2-oxazol-5-yl]-3-methyl-butanoyl]-N-[(1S)-1-[4-(4-methyl-1,3-thiazol-5-yl)phenyl]ethyl]-4-oxidanyl-pyrrolidine-2-carboxamide(Non-covalent)
- Links
- RCSB PDBe PDBe-KB PDBj PDBsum CATH PLIP
- Citation
- Berlin, M. et al., PROTACs Targeting BRM (SMARCA2) Afford Selective In Vivo Degradation over BRG1 (SMARCA4) and Are Active in BRG1 Mutant Xenograft Tumor Models. J.Med.Chem. (2024)
- Release Date
- 2024-01-17
- Peptides
- Elongin-B: A
Elongin-C: B
von Hippel-Lindau disease tumor suppressor: C
Transcription activator BRG1: D - SMTL:PDB
- SMTL Chain Id:
PDB Chain Id:A
AB
BC
CD
G